Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C35H64N2O2 |
| Molecular Weight | 544.8949 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
| Stereo Comments | Assumed racemic |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCOCC(CN1CCC(CN)(CC1)C2=CC=CC=C2)OCCCCCCCCCC
InChI
InChIKey=UXKVQQGVROWOMG-UHFFFAOYSA-N
InChI=1S/C35H64N2O2/c1-3-5-7-9-11-13-15-20-28-38-31-34(39-29-21-16-14-12-10-8-6-4-2)30-37-26-24-35(32-36,25-27-37)33-22-18-17-19-23-33/h17-19,22-23,34H,3-16,20-21,24-32,36H2,1-2H3
| Molecular Formula | C35H64N2O2 |
| Molecular Weight | 544.8949 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:18:39 UTC 2023
by
admin
on
Sat Dec 16 14:18:39 UTC 2023
|
| Record UNII |
H43V0Q3IZT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
126457
Created by
admin on Sat Dec 16 14:18:39 UTC 2023 , Edited by admin on Sat Dec 16 14:18:39 UTC 2023
|
PRIMARY | |||
|
72618-09-8
Created by
admin on Sat Dec 16 14:18:39 UTC 2023 , Edited by admin on Sat Dec 16 14:18:39 UTC 2023
|
PRIMARY | |||
|
H43V0Q3IZT
Created by
admin on Sat Dec 16 14:18:39 UTC 2023 , Edited by admin on Sat Dec 16 14:18:39 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
ASSUMED ALPHA OTHER PKC MAY ALSO BE INHIBITED
IC50
|
||
|
SALT/SOLVATE -> PARENT | |||
|
CELL->INHIBITOR |
THERAPEUTIC INDEX LESS THAN 1
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
